Quantitative PCR identifies a minimal deleted region of 120 kb extending from the Philadelphia chromosome ABL translocation breakpoint in chronic myeloid leukemia with poor outcome
Open Access
- 20 June 2003
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 17 (7) , 1313-1323
- https://doi.org/10.1038/sj.leu.2402969
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapyLeukemia, 2002
- Progress with Chronic Myelogenous Leukemia: A Personal Perspective over Four DecadesAnnual Review of Medicine, 2002
- Blockade of the Bcr-Abl Kinase Activity Induces Apoptosis of Chronic Myelogenous Leukemia Cells by Suppressing Signal Transducer and Activator of Transcription 5–Dependent Expression of Bcl-XLThe Journal of Experimental Medicine, 2000
- Role of abnormal integrin-cytoskeletal interactions in impaired β1 integrin function in chronic myelogenous leukemia hematopoietic progenitorsExperimental Hematology, 1999
- Chronic Myeloid LeukemiaNew England Journal of Medicine, 1999
- BCR/ABL induces multiple abnormalities of cytoskeletal function.Journal of Clinical Investigation, 1997
- Role of Focal Adhesion Proteins in Signal Transduction and OncogenesisCritical Reviews™ in Oncogenesis, 1997
- Clinical features at diagnosis in 430 patients with chronic myeloid leukaemia seen at a referral centre over a 16‐year periodBritish Journal of Haematology, 1997
- Definition of the accelerated phase of chronic myelogenous leukemia.Journal of Clinical Oncology, 1988
- Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemiaNature, 1987